{"id":1048722,"date":"2012-07-08T15:45:16","date_gmt":"2012-07-08T15:45:16","guid":{"rendered":"http:\/\/www.immortalitymedicine.tv\/chemistry\/chemistry-world-entrepreneur-of-the-year-award-2012.php"},"modified":"2024-08-17T17:58:12","modified_gmt":"2024-08-17T21:58:12","slug":"chemistry-world-entrepreneur-of-the-year-award-2012","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/chemistry\/chemistry-world-entrepreneur-of-the-year-award-2012.php","title":{"rendered":"Chemistry World Entrepreneur of the Year Award 2012"},"content":{"rendered":"

\"\"<\/a><\/p>

This year’s Chemistry World<\/em> Entrepreneur of the Year Award<\/a> has been given to Paul <\/strong>Workman<\/a> <\/strong>‘for his work as a scientific pioneer and serial entrepreneur whose numerous commercialised discoveries and academic research led to his founding two successful chemical companies: Piramed Pharma<\/a> and Chroma Therapeutics<\/a>‘.<\/p>

The award is an international accolade that recognises an individual’s contribution to the commercialisation of research. Awarded annually, the winner is featured in Chemistry World<\/em> and receives £4000 and a trophy.<\/span><\/p>

Workman is a chemical biologist and molecular pharmacologist at the Institute of Cancer Research<\/a> (ICR) where he is currently deputy chief executive and director of the ICR’s Cancer Research UK Cancer Therapeutics Unit in Sutton, UK. He has been responsible for a large number of new cancer drugs and his unit at ICR has discovered 16 preclinical development candidates over the last six years.<\/p>

Upon hearing of the award, Workman spoke of the importance of creating a great team and of his motivation to work in drug discovery: ‘Successful drug discovery is incredibly complex and requires not just scientific expertise but also great people. It has been a real privilege for me to build a high-performing, multidisciplinary team and to collaborate with some fantastic colleagues. Also, because we want to bring effective new drugs<\/p>

\"\"<\/a>

— <\/span>Paul Workman<\/p><\/div><\/div>

to patients as fast possible, it’s been important for us to build a network of commercial collaborations. But the main motivation for me is that the drugs we discover through our science have a real impact on the lives of cancer patients.’<\/p>

Karl Coleman<\/a> of Durham Graphene Science<\/a> and Hagan Bayley<\/a> of Oxford Nanopore Technologies<\/a> are previous winners of the award. A feature length article on Workman will be published  in the September issue of Chemistry World<\/em>.<\/p>

Bibiana Campos Seijo<\/em><\/p>

\"Digg<\/a>  \"Reddit<\/a>  \"Stumble<\/a>  \"Share<\/a>  \"Bookmark<\/a>  \"Share<\/a>  \"Bookmark<\/a>  \"Post<\/a>  \"Google<\/a>  <\/div>

Source:
http:\/\/prospect.rsc.org\/blogs\/cw\/?feed=rss2<\/a><\/p>","protected":false},"excerpt":{"rendered":"

This year’s Chemistry World Entrepreneur of the Year Award has been given to Paul Workman ‘for his work as a scientific pioneer and serial entrepreneur whose numerous commercialised discoveries and academic research led to his founding two successful chemical companies: … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246863],"tags":[],"class_list":["post-1048722","post","type-post","status-publish","format-standard","hentry","category-chemistry"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1048722"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1048722"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1048722\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1048722"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1048722"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1048722"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}